// App-Quantinova.ai

: Alirocumab and Cardiovascular Outcomes in Patients with Acute Coronary Syndrome (ACS) and Diabetes—Prespecified Analyses of ODYSSEY OUTCOMES

Researchers

Presenter

  • KAUSIK K. RAY

Principal Investigators

  • MICHAEL SZAREK

  • MARIE BACCARA-DINET

  • DEEPAK L. BHATT

  • VERA BITTNER

  • ANDRZEJ J. BUDAJ

  • RAFAEL DIAZ SR

  • SHAUN G. GOODMAN

  • CORINNE G. HANOTIN

  • J. WOUTER JUKEMA

  • VIRGINIE LOIZEAU

  • RENATO D. LOPES

  • ANGELE MORYUSEF

  • ROBERT PORDY

  • ARSEN D. RISTIC

  • MATTHEW ROE

  • JOSa TUaaN

  • HARVEY D. WHITE

  • GREGORY G. SCHWARTZ

  • PHILIPPE G. STEG

Medical Centers

  • N/A

Locations

  • United Kingdom

  • United States

  • France

  • Poland

  • Argentina

  • Canada

  • Netherlands

  • Serbia

  • Spain

  • New Zealand

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • N/A

Biomarkers

  • Proprotein convertase subtilisin/kexin type 9

Drug/Treatment

  • Atorvastatin

  • Rosuvastatin

  • Alirocumab

Outcome

  • N/A

Study Design

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved